Skip to main content
    J

    Jazz Pharmaceuticals PLC (JAZZ)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $240.71
    +0.94 (+0.39%)

    Market Cap: $15.39B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Jazz Pharmaceuticals PLC (JAZZ) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Jazz Pharmaceuticals (JAZZ) has a latest price of $240.71 on Nov 17, 2026, 9.6% below its 52-week high of $266.38. Its price rose 70.6% over the past 12 months. The month-end price rose 97.3% over the 10 years through Oct 2026, a compound annual rate of 7.0%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $252.86 in Jul 2026 and its lowest $99.74 in Mar 2020, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart JAZZ with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for JAZZ.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 4.5%, and over 6 months it rose 1.4%. The month-end price rose 70.0% over the 3 years through Oct 2026, a compound annual rate of 19.4%.

    PeriodChange
    1 month+15.5%
    3 months-4.5%
    6 months+1.4%
    12 months+70.6%
    12 months, with dividends+70.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+70.0%+19.4%
    5 years+62.3%+10.2%
    10 years+97.3%+7.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 38.0%, and its weakest was 2021, when it fell 22.8%.

    YearCloseChange
    2026 through Oct 2026$215.98+27.0%
    2025$170.00+38.0%
    2024$123.15+0.1%
    2023$123.00-22.8%
    2022$159.31+25.0%
    2021$127.40-22.8%
    2020$165.05+10.6%
    2019$149.28+20.4%
    2018$123.96-7.9%
    2017$134.65+23.5%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 5.1% above its 50-day average of $229.00 and 9.0% above its 200-day average of $220.77.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$240.71
    52-week high$266.38-9.6%
    52-week low$156.95+53.4%
    50-day average$229.00+5.1%
    200-day average$220.77+9.0%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 32.2%.

    MeasureValue
    1-year beta0.70
    Largest fall, 1 year-21.6%
    Largest fall, 3 years-32.2%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Jazz Pharmaceuticals traded at 24.1x earnings at the end of 2025, against a 5-year median of 9.5x and a 10-year median of 10.0x.

    JAZZ valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About JAZZ

    What is JAZZ's 1-year price change?

    Jazz Pharmaceuticals's price rose 70.6% over the past 12 months. With dividends included, the 12-month total return was 70.6%.

    What is JAZZ's 5-year price change?

    Jazz Pharmaceuticals's month-end price rose 62.3% over the 5 years through Oct 2026, a compound annual rate of 10.2%. These figures leave out dividends.

    What is JAZZ's 52-week high and low?

    Jazz Pharmaceuticals's 52-week high is $266.38 and its 52-week low is $156.95. Its latest price of $240.71 on Nov 17, 2026 is 9.6% below the high.

    What is JAZZ's beta?

    Jazz Pharmaceuticals's 1-year beta against the S&P 500 is 0.70, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 21.6%.

    Is the JAZZ chart free?

    Yes. Advanced Charting for JAZZ is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.